Epilepsy and Seizure News
Neurofeedback News
Rewiring Your Brain: Neurofeedback Goes Mainstream -
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Will Strahl walked up to my door with a massive black briefcase in his ...
Can Neurofeedback Effectively Treat ADHD? -
Neurofeedback training is an alternative therapy that uses real-time EEG data to help patients train their brains to improve focus, impulse control, and executive function. Since the 1970s, patients ...
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
Can Monitoring Brain Waves Boost Mental Health? -
Neurofeedback has promised a mental health revolution for decades. But is it effective? Credit...Tony Luong for The New York Times Supported by By David Dodge Twice a week, Stephanie, a 37-year-old ...
What Does a Neurofeedback Technician Do? -
Neurofeedback is about helping a client's brain learn to self-regulate by showing it its own EEG activity on a screen or through headphones. It is like going to the gym for your brain. It is not a ...
Medical News Today
PubMed
Open-Loop Deep Brain Stimulation Versus Closed-Loop Responsive Neurostimulation in Drug-Resistant Bitemporal Epilepsy: A Narrative Review -
Drug-resistant bitemporal epilepsy presents a therapeutic challenge when resective surgery is not feasible due to bilateral seizure onset or eloquent cortex involvement. Neuromodulation has emerged as an alternative, with open-loop deep brain stimulation (DBS) and closed-loop responsive neurostimulation (RNS) as implantable strategies. Comparative indications for modality selection remain uncle...
Limited sex-specific structural alterations across common epilepsies: A worldwide ENIGMA study -
OBJECTIVE: Epilepsy is characterized by widespread cortical and subcortical structural alterations beyond the epileptic zone. Importantly, the clinical manifestation of epilepsy, including seizure types, psychiatric comorbidities, and treatment responses, has been shown to differ between sexes. However, sex differences in structural alterations in epilepsy are seldomly reported in neuroimaging ...
Affective symptoms in focal epilepsy: A scoping review of localization and lateralizing findings -
Emotional experiences during focal seizures are often misinterpreted as psychiatric disorders. We aimed to evaluate symptoms involving affective symptoms at seizure onset. We aimed to identify the most prevalent affective symptoms at seizure onset and characterize their localizing and lateralizing value. We performed a scoping review based on Preferred Reporting Items for Systematic reviews and...
Fenfluramine treatment and seizure-free days in pediatric and adult patients with Lennox-Gastaut syndrome: A post hoc analysis -
The most common primary endpoint for assessing treatment efficacy in patients with Lennox-Gastaut syndrome (LGS) is change in frequency of seizures associated with a fall. Increased number of seizure-free days (SFDs) is more strongly associated with improved quality of life than seizure frequency reduction. Fenfluramine is approved for treatment of seizures associated with LGS in patients ≥2 ye...
The basal ganglia and the epilepsies -
The basal ganglia are an evolutionarily conserved neural circuit best known for the selection and sequencing of voluntary movement. Increasing evidence, however, indicates that these structures also play an important role in regulating pathological brain states, including seizures. Early pharmacological and lesion studies demonstrated that manipulation of basal ganglia output nuclei, particular...
Genetic developmental and epileptic encephalopathies in adulthood: Gaps in evidence and care -
Developmental and epileptic encephalopathies (DEEs) are a heterogeneous group of the most severe epilepsies, characterized by seizure onset and neurodevelopmental delay in infancy or childhood, often with additional neurological and systemic comorbidities. Up to 50% of cases have an identifiable genetic cause, with structural etiologies representing a small minority. Although associated with ea...
Science Daily